Literature DB >> 7315721

Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance.

L A Reduto, G C Freund, J M Gaeta, R W Smalling, B Lewis, K L Gould.   

Abstract

Coronary angiography was performed on hospital admission in 37 patients with acute myocardial infarction (AMI). Thirty patients had total occlusion of the infarct-related coronary artery and seven patients had severe proximal stenoses with poor distal flow. In 20 of 30 patients with total occlusion, intracoronary (IC) infusion of streptokinase (SK) resulted in reperfusion of the distal coronary artery. Left ventricular (LV) performance was assessed before coronary angiography and at discharge from the hospital by use of gated cardiac blood pool imaging techniques. In patients evidencing reperfusion of the infarct-related coronary artery, mean (+/- SD) left ventricular ejection fraction (LVEF) increased from admission through discharge (46% +/- 15% to 55% +/- 10%, p = 0.002). In contrast, LVEF did not change from admission through discharge in patients with severe proximal stenoses alone or in patients with total occlusion who did not demonstrate reperfusion following SK administration (47% +/- 17% vs 49% +/- 18%, p = ns). In an additional 14 control patients with AMI who were not evaluated with coronary angiography, LVEF did not change from admission through discharge (46% +/- 12% vs 48% +/- 14%, p = ns). Quantitative thallium-201 perfusion imaging demonstrated an increase (p less than 0.05) in thallium uptake in the infarct segment following coronary artery reperfusion. In contrast, thallium uptake did not change (p = ns) in the infarct segment in patients not evidencing angiographic coronary artery reperfusion. These data support the following : (1) Coronary artery thrombus occurs frequently in AMI and can be lysed by IC SK, and (2) reperfusion with IC SK in patients with evolving myocardial infarction results in myocardial salvage and improved LV performance through hospital discharge.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7315721     DOI: 10.1016/0002-8703(81)90648-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Assessment of Regional Viability in the Infarct Zone Following Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction.

Authors:  K Shimada; Y Sakanoue; Y Kobayashi; S Ehara; M Hirose; Y Nakamura; D Fukuda; H Yamagishi; M Yoshiyama; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

3.  Outcome of early surgery after coronary angioplasty.

Authors:  M S Norell; J Lyons; C Layton; R Balcon
Journal:  Br Heart J       Date:  1986-03

4.  Emergency coronary artery bypass surgery after intracoronary thrombolysis for evolving myocardial infarction.

Authors:  P Kay; A Ahmad; S Floten; A Starr
Journal:  Br Heart J       Date:  1985-03

Review 5.  Thrombolytic therapy in acute myocardial infarction. A perspective.

Authors:  S Sherry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Intracoronary thrombolysis in acute myocardial infarction.

Authors:  N Brooks
Journal:  Br Heart J       Date:  1983-11

7.  Angiographic features of the coronary arteries during intracoronary thrombolysis.

Authors:  P Terrosu; G V Ibba; G M Contini; V Franceschino
Journal:  Br Heart J       Date:  1984-08

8.  Intracoronary thrombolysis in evolving myocardial infarction. Sequential angiographic analysis of left ventricular performance.

Authors:  A Cribier; J Berland; O Champoud; N Moore; P Behar; B Letac
Journal:  Br Heart J       Date:  1983-11

Review 9.  Stunning: damaging or protective to the myocardium?

Authors:  R Ferrari; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

10.  Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator.

Authors:  B E Sobel; L E Fields; A K Robison; K A Fox; S J Sarnoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.